The WHI Estrogen-Alone Trial—Do Things Look Any Better?

The findings of the Heart and Estrogen/progestin Replacement Study and Women's Health Initiative (WHI) led the FDA to recommend that estrogen preparations not be used to prevent coronary heart disease or considered first-line therapy for prevention of osteoporosis. In summary, the WHI trials su...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JAMA : the journal of the American Medical Association 2004-04, Vol.291 (14), p.1769-1771
Hauptverfasser:	Hulley, Stephen B, Grady, Deborah
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials Coronary Disease - epidemiology Coronary Disease - prevention & control Estrogen Replacement Therapy - adverse effects Estrogens Estrogens - adverse effects Estrogens - therapeutic use Estrogens, Conjugated (USP) - adverse effects Estrogens, Conjugated (USP) - therapeutic use Female Hormone replacement therapy Humans Menopause Postmenopause Risk Assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!